Evidence map›Paper›PMID 33975909›Full record

ArticleDiabetes2021

Tribbles Homolog 3 Mediates the Development and Progression of Diabetic Retinopathy.

Priyamvada M Pitale, Irina V Saltykova, Yvonne Adu-Agyeiwaah, Sergio Li Calzi, Takashi Satoh, Shizuo Akira, Oleg Gorbatyuk, Michael E Boulton, Machelle T Pardue, W Timothy Garvey and 3 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Proteomic analysis of diabetic retinas.Frontiers in endocrinology · 2023
    Article
  13. GADD34 Ablation Exacerbates Retinal Degeneration in P23H RHO Mice.International journal of molecular sciences · 2022
    Article
  14. Diabetic Retinopathy: From Animal Models to Cellular Signaling.International journal of molecular sciences · 2022
    Review
  15. Frontiers in genetics · 2022
    Article
  16. Review
  17. A Novel Tree Shrew Model of Diabetic Retinopathy.Frontiers in endocrinology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Priyamvada M PitaleDepartment of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL.
Irina V SaltykovaDepartment of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL.
Yvonne Adu-AgyeiwaahDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL.
Sergio Li CalziDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL.
Takashi SatohDepartment of Immune Regulation, Tokyo Medical and Dental University, Tokyo, Japan.
Shizuo AkiraWPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Oleg GorbatyukDepartment of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL.
Michael E BoultonDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL.
Machelle T PardueDepartment of Biomedical Engineering, Georgia Institute of Technology, and Atlanta VA Center of Excellence for Visual and Neurocognitive Rehabilitation.
W Timothy GarveyDepartment of Nutrition Sciences and Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL.
Mohammad AtharSchool of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Maria B GrantDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL.
Marina S GorbatyukDepartment of Optometry and Vision Science, School of Optometry, University of Alabama at Birmingham, Birmingham, AL mgortk@uab.edu.ORCID 0000-0001-9060-856X
University of Alabama at Birmingham · USGeorgia Institute of Technology · USThe University of Osaka · JPTokyo Medical and Dental University · JP

Funding

Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2000 to 2026
$31.9M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul Douglas Gamlin · 1985 to 2026
$16.9M
Post-translational histone modification in ocular tissues of mice exposed to arsenicalsR01EY027763 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GORBATYUK, MARINA · 2018 to 2022
$2.0M
Development and Validation of a Tree Shrew Model of Diabetic RetinopathyR21EY031103 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GORBATYUK, MARINA · 2019 to 2019
$297k
NEI NIH HHS P30 EY003039NEI NIH HHS R01 EY027763NEI NIH HHS R21 EY031103NIDDK NIH HHS P30 DK056336NIDDK NIH HHS P30 DK079626RRD VA IK6 RX003134
6 · The paper itself

Abstract

The current understanding of the molecular pathogenesis of diabetic retinopathy does not provide a mechanistic link between early molecular changes and the subsequent progression of the disease. In this study, we found that human diabetic retinas overexpressed TRIB3 and investigated the role of TRIB3 in diabetic retinal pathobiology in mice. We discovered that TRIB3 controlled major molecular events in early diabetic retinas via HIF1α-mediated regulation of retinal glucose flux, reprogramming cellular metabolism, and governing of inflammatory gene expression. These early molecular events further defined the development of neurovascular deficit observed in mice with diabetic retinopathy. TRIB3 ablation in the streptozotocin-induced mouse model led to significant retinal ganglion cell survival and functional restoration accompanied by a dramatic reduction in pericyte loss and acellular capillary formation. Under hypoxic conditions, TRIB3 contributed to advanced proliferative stages by significant upregulation of GFAP and VEGF expression, thus controlling gliosis and aberrant vascularization in oxygen-induced retinopathy mouse retinas. Overall, our data reveal that TRIB3 is a master regulator of diabetic retinal pathophysiology that may accelerate the onset and progression of diabetic retinopathy to proliferative stages in humans and present TRIB3 as a potentially novel therapeutic target for diabetic retinopathy.

Indexed as

AnimalsCapillariesCell Cycle ProteinsDiabetes Mellitus, ExperimentalDiabetic RetinopathyDisease ProgressionHumansMicePericytesProtein Serine-Threonine KinasesRepressor ProteinsRetinaCell Cycle ProteinsProtein Serine-Threonine KinasesRepressor ProteinsTRIB3 protein, human

Identifiers

PMID33975909
PMCPMC8385618
OpenAlexW3163854057

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.